Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes

This publication has 22 references indexed in Scilit:

• Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes
  Clinical Pharmacology & Therapeutics, 1984
• Bufuralol metabolism in human liver: a sensitive probe for the debrisoquine‐type polymorphism of drug oxidation
  European Journal of Clinical Investigation, 1984
• Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugs
  Life Sciences, 1984
• Correlation between nortriptyline and debrisoquine hydroxylation in the human liver
  Life Sciences, 1983
• The debrisoquine hydroxylation test predicts steady‐state plasma levels of desipramine.
  British Journal of Clinical Pharmacology, 1983
• Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.
  Published by Wiley ,1981
• A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.
  Journal of Medical Genetics, 1980
• POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
  The Lancet, 1977
• Pharmacokinetics of desmethylimipramine and nortriptyline in man after single and multiple oral doses ? A cross-over study
  European Journal of Clinical Pharmacology, 1972
• Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds
  Life Sciences, 1967